Daito Pharmaceutical Co., Ltd. (4577)

Market cap
¥42.2B
P/E ratio
16.6x
Daito manufactures active pharmaceutical ingredients and prescription drugs for domestic and international pharmaceutical companies. The company offers an integrated production system from raw materials to final formulations.
Period EndRevenue growth (%) YoY (%)
May 31, 20258+100.75%
May 31, 20244+5.57%
May 31, 20233.8-134.97%
May 31, 2022-10.8-230.19%
May 31, 20218.3-11.73%
May 31, 20209.4+196.84%
May 31, 20193.2-36.55%
May 31, 20185+12.16%
May 31, 20174.4-34.61%
May 31, 20166.8-26.03%
May 31, 20159.2+18.60%
May 31, 20147.7+16.39%
May 31, 20136.7
AI Chat